“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States-Reference-Cited by-同舟云学术

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

Published:2015-11-18 Issue:4 Volume:88 Page:535-544
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Larmore Cynthia¹,Effron Mark B.¹,Molife Cliff¹,DeKoven Mitch²,Zhu Yajun¹,Lu Jingsong²,Karkare Swapna²,Lieu Hsiao D.¹,Lee Won Chan²,Vetrovec George W.³

Affiliation:

1. Eli Lilly and CompanyUS Medical AffairsIndianapolis Indiana

2. IMS HealthHealth Economics and Outcomes Research/Real World Evidence SolutionsPlymouth Meeting PA

3. VCU Pauley Heart CenterRichmond Virginia

Funder

Daiichi Sankyo Inc, Parsippany, NJ; Eli Lilly and Company, Indianapolis, IN

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.26279

Reference24 articles.

1. American Heart Association Statistics Committee Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: A report from the American Heart Association;Mozaffarian D;Circulation,2015

2. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

3. 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara PT;Circulation,2013

4. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

5. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-derived circFAM13B associated with anti-platelet responsiveness of ticagrelor in patients with acute coronary syndrome;Thrombosis Journal;2024-06-21

2. Contribution of platelet-derived circFAM13B to the antiplatelet effectiveness of ticagrelor in patients with acute coronary syndrome;2024-04-18

3. Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome;Journal of Thrombosis and Thrombolysis;2024-03-31

4. Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention;Research and Practice in Thrombosis and Haemostasis;2024-03

5. Comparison of Clinical Outcomes in Acute Coronary Syndrome Patients Who Undergo Percutaneous Coronary Intervention Using Different P2Y12 Inhibitors: A SMS Hospital Based Observational Study;2023-12-05